Inventor · disambiguated record
Ross Anthony Stewart
Also filed as: STEWART ROSS · STEWART ROSS A · STEWART ROSS ANTHONY
6 granted patents·10 pending applications·465 citations·filing 2008–2022
82Inventor score
Files withMEDIMMUNE LTD10ASTRAZENECA AB1ASTRAZENECA PHARMACEUTICALS LP1MEDIMMUNE LLC1MERCK PATENT GMBH1
Top patents by PatentIndex Score
16 records- 0195US8779108B2Targeted binding agents against B7-H1QUEVA CHRISTOPHE·Filed 2010·Granted Jul 15, 2014·452 cites·31 claims
- 0290US10400039B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2016·Granted Sep 3, 2019·8 cites·8 claims
- 0380US2023235062A1Targeted binding agents against b7-h1MEDIMMUNE LTD·Filed 2022·Application pending·0 cites
- 0474US10092645B2Methods of treatment with antagonists against PD-1 and PD-L1 in combination with radiation therapyMEDIMMUNE LTD·Filed 2015·Granted Oct 9, 2018·3 cites·17 claims
- 0568US10077305B2Antibodies against PD-1 and uses thereofMEDIMMUNE LTD·Filed 2014·Granted Sep 18, 2018·1 cites·11 claims
- 0667US11518809B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2019·Granted Dec 6, 2022·0 cites·11 claims
- 0763US2022073622A1Compositions and Methods for Treating Late Stage Lung CancerASTRAZENECA AB·Filed 2021·Application pending·0 cites
- 0861US10428131B2GITRL fusion proteins comprising a human coronin 1a derived trimerization domainMEDIMMUNE LTD·Filed 2016·Granted Oct 1, 2019·1 cites·20 claims
- 0952US2020140510A1Gitrl fusion proteins and uses thereofMEDIMMUNE LTD·Filed 2019·Application pending·0 cites
- 1048US2010184959A1Polypeptide VariantsMEDIMMUNE LTD·Filed 2008·Application pending·0 cites
- 1145US2019192655A1Methods of treatment with antagonists against pd-1 and pd-l1 in combination with radiation therapyMEDIMMUNE LTD·Filed 2018·Application pending·0 cites
- 1244US2019276543A1Compositions and methods for treating late stage lung cancerASTRAZENECA PHARMACEUTICALS LP·Filed 2018·Application pending·0 cites
- 1342US2020254091A1Combination of a PARP Inhibitor and a PD-1 Axis Binding AntagonistMERCK PATENT GMBH·Filed 2018·Application pending·0 cites
- 1435US2016347848A1Therapeutic combinations and methods for treating neoplasiaMEDIMMUNE LTD·Filed 2016·Application pending·0 cites
- 1531US2016031990A1Antagonists of pdl-1 and pd-1 for the treatment of hpv-negative cancersMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 1629US2016060344A1Combination therapy for pd-l1 negative tumorsNARWAL RAJESH·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →